EVOFEM BIOSCIENCES
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
EVOFEM BIOSCIENCES
Industry:
Biopharma Health Care Medical Women's
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.evofem.com
Total Employee:
101+
Status:
Active
Contact:
+858.550.1900
Email Addresses:
[email protected]
Total Funding:
470.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-01-17 | Neothetics | Neothetics acquired by Evofem Biosciences | N/A |
Investors List
Keystone Capital
Keystone Capital investment in Post-IPO Equity - Evofem Biosciences
Adjuvant Capital
Adjuvant Capital investment in Post-IPO Debt - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
PDL Biopharma
PDL Biopharma investment in Post-IPO Equity - Evofem Biosciences
Woodford Investment Management
Woodford Investment Management investment in Post-IPO Equity - Evofem Biosciences
Domain Associates
Domain Associates investment in Series C - Evofem Biosciences
AKS Capital
AKS Capital investment in Series C - Evofem Biosciences
Alta Partners
Alta Partners investment in Series C - Evofem Biosciences
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series C - Evofem Biosciences
RUSNANO
RUSNANO investment in Series C - Evofem Biosciences
Official Site Inspections
http://www.evofem.com Semrush global rank: 1.24 M Semrush visits lastest month: 24.44 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
